Hy-Tech Weight Loss vs Pritikin Franchise Comparison
Below is an in-depth analysis and side-by-side comparison of Hy-Tech Weight Loss vs Pritikin including start-up costs and fees, business experience requirements, training & support and financing options.
Start-Up Costs and Fees |
Investment |
$44,100 - $117,500 | $26,069 - $70,713 |
Franchise Fee |
N/A | N/A |
Royalty Fee |
- | 17.5% |
Advertising Fee |
- | - |
Year Founded |
2004 | 2013 |
Year Franchised |
2005 | 2013 |
Term Of Agreement |
- | - |
Term Of Agreement |
- | - |
Renewal Fee |
- | - |
Business Experience Requirements |
Experience |
- | - |
Financing Options |
|
In-House/3rd Party | In-House/3rd Party |
Franchise Fees |
-/- | -/- |
Start-up Costs |
-/- | -/- |
Equipment |
-/- | -/- |
Inventory |
-/- | -/- |
Receivables |
-/- | -/- |
Payroll |
-/- | -/- |
Training & Support |
Training |
- | - |
Support |
- | - |
Marketing |
- | - |
Operations |
- | - |
Expansion Plans |
US Expansion |
- | - |
Canada Expansion |
- | - |
International Expansion |
- | - |
Company Overviews
About Hy-Tech Weight Loss
NO LONGER FRANCHISING
About Pritikin
Pritikin offers licenses under which health care providers such as hospitals and
cardiology practices can become certified to operate a portion of their
existing health care business as a “Pritikin-certified” provider.
“Pritikin-certified” programs offer and teach intensive cardiac
rehabilitation programs to their patients using Pritikin’s proprietary
“Pritikin” intensive cardiac rehabilitation program. These health care
providers will conduct the Pritikin-certified Program for patients at
their existing health care facilities.
The
Pritikin Program is proven to prevent, control, or reverse risk factors
for a multiplicity of diseases, ailments, and conditions including:
-Heart Disease, Angina Pain, Hypertension, Type 2 Diabetes, Metabolic Syndrome, Insulin Resistance, Excess Weight/Obesity, Prostate Cancer, Breast Cancer,
Colon Cancer, High Cholesterol, High Triglycerides, Peripheral Artery Disease, Benign Prostatic Hyperplasia and Chronic Inflammation.